Nevro Overview
Nevro Target Price
Nevro target price — quarterly history, peer benchmarks, and growth trends.
Get informed when a big investor buys or sells
+ FollowShare Price
$5.84
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-12-02 | Morgan StanleyKallum Titchmarsh | $4 |  31.5% downside |  |
| 2024-10-15 | Robert W. BairdDavid Rescott | $5 | 14.4% downside | |
| 2024-08-08 | CitigroupJoanna Wuensch | $6.89 |  18% upside | |
| 2024-08-08 | Truist FinancialRichard Newitter | $5.5 | 5.8% downside | |
| 2024-08-07 | Robert W. BairdDavid Rescott | $8 | 37% upside | |
| 2024-08-07 | JefferiesMatthew Taylor | $7 | 19.9% upside | |
| 2024-08-07 | Piper SandlerAdam Maeder | $7 | 19.9% upside | |
| 2024-08-07 | Wells FargoNathan Treybeck | $5.5 | 5.8% downside | |
| 2024-04-11 | Mizuho SecuritiesAnthony Petrone | $16 | 174% upside | |
| 2024-04-08 | Wells FargoNathan Treybeck | $14 | 139.7% upside | |
| 2023-06-06 | OppenheimerSuraj Kalia | $40 | 584.9% upside | |
| 2023-02-06 | Canaccord Genuity | $72 | 1132.9% upside | |
| 2023-01-06 | Piper Sandler | $38 | 550.7% upside | |
| 2022-12-25 | Canaccord GenuityCanaccord Canaccord | $67 | 1047.3% upside | |
| 2022-12-20 | Truist Financial | $41 | 602.1% upside | |
| 2022-12-12 | Wells Fargo | $43 | 636.3% upside | |
| 2022-02-24 | JMP SecuritiesDavid Turkaly | $125 | 2040.4% upside | |
| 2022-02-24 | J.P. MorganRobbie Marcus | $70 | 1098.6% upside | |
| 2021-12-15 | CitigroupJoanne Wuensch | $94 | 1509.6% upside | |